☆ 4.4 Article

Time Course of Neutralizing Antibody in Health Care Workers With Mild or Asymptomatic COVID-19 Infection

OPEN FORUM INFECTIOUS DISEASES (2021)

Related references

Note: Only part of the references are listed.

Article Infectious Diseases

Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)

Cristina Mussini et al.

Summary: This study summarized the literature on the management of COVID-19 to assist frontline healthcare workers in better understanding the current evidence for disease treatment and guidelines. The research team conducted a detailed review of literature and clinical trial results to develop treatment indications for different COVID-19 patients.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection

Article Multidisciplinary Sciences

Evolution of antibody immunity to SARS-CoV-2

Christian Gaebler et al.

Summary: After infection with SARS-CoV-2, antibody levels against the spike protein decrease significantly, but the number of memory B cells remain unchanged, indicating an evolving humoral response at 6.2 months after infection.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers

Stephane Marot et al.

Summary: This study found that SARS-CoV-2 infection can induce neutralizing antibody response correlated with antibody levels, but this neutralizing activity declines after two months post-disease onset, suggesting the need for maintaining infection prevention measures and considering periodic vaccination boosts.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Immunology

Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses

Stephan Schlickeiser et al.

Summary: Clinical trials on the use of COVID-19 convalescent plasma have shown inconclusive results, with some patients potentially benefiting from the treatment of convalescent plasma neutralizing antibodies. Studies suggest that COVID-19 patients requiring hospitalization and experiencing fever symptoms may have higher risk of having lower levels of neutralizing antibodies.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Infectious Diseases

Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection

Ilaria Vicenti et al.

Summary: Vaccination after infection can boost neutralizing antibody levels significantly higher than in uninfected individuals. Asymptomatic individuals with previous infection show a significant increase in neutralizing antibody titres after receiving the first vaccine dose.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Public, Environmental & Occupational Health

The experience of the health care workers of a severely hit SARS-CoV-2 referral Hospital in Italy: incidence, clinical course and modifiable risk factors for COVID-19 infection

Marta Colaneri et al.

Summary: During the COVID-19 pandemic, early hit hospitals have effectively implemented standard infection control practices to combat the virus. Research shows that working in COVID-19 wards, former smoking history, and higher BMI are positively associated with SARS-CoV-2 infection, while current smoking is negatively correlated.

JOURNAL OF PUBLIC HEALTH (2021)

Add to Collection

Article Immunology

Neutralizing Antibody Responses in COVID-19 Convalescent Sera

William T. Lee et al.

Summary: Passive transfer of antibodies from COVID-19 convalescent patients is used as an experimental treatment for SARS-CoV-2 infections. As time post symptom onset increases, neutralizing activity in sera significantly rises to reach a peak, emphasizing the value of serum characterization for neutralization activity.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Review Infectious Diseases

Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines

Florian Krammer et al.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2020)

Add to Collection

Article Multidisciplinary Sciences

DNA vaccine protection against SARS-CoV-2 in rhesus macaques

Jingyou Yu et al.

SCIENCE (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study

Long H. Nguyen et al.

LANCET PUBLIC HEALTH (2020)

Add to Collection

Article Respiratory System

SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital

Giovanni Sotgiu et al.

BMC PULMONARY MEDICINE (2020)

Add to Collection

Review Multidisciplinary Sciences

A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

Angkana T. Huang et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Medicine, General & Internal

Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China

Fan Wu et al.

JAMA INTERNAL MEDICINE (2020)

Add to Collection

Article Oncology

The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures

Alberto Dalla Volta et al.

FRONTIERS IN ONCOLOGY (2020)

Add to Collection

Article Immunology

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection

Catherine J. Reynolds et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

© Peeref 2019-2024. All rights reserved.